Multistrada rights issue IDR1.53 trio

BI/market

3/11/2011

Irvin Avriano A.

Bisnis Indonesia

Multistrada rights issue IDR1.53 trio

JAKARTA: PT Multistrada Arah Sarana Tbk, automobile and motorcycle tires producer listed company , will held rights issue worth IDR1.53 trio.

Data in their prospectus today explain the corporate action will held by issue 3.06 billion shares or 33.33% portion with nominal value IDR140 at execution price IDR500.

Panin Financial to rights issue IDR499.25 bio

Irvin Avriano A.

Panin Financial to rights issue IDR499.25 bio

JAKARTA: PT Panin Financial Tbk, a business and management consultant company from Panin Group, disclose its VII/2011 rights issue plan with fund targets IDR499.25 billion and IDR998.5 bio if added with its warrants.

The matter was conclude in its information disclosure published in newspaper today. The company that led by Fadjar Gunawan is intend to dispose 3.99 bio new shares with nominal and offered price IDR125.

Chandra Petrochemical surged after low rights issue price

16/5/2011

Irvin Avriano A.

Chandra Petrochemical surged after low rights issue price

JAKARTA: PT Chandra Asri Petrochemical Tbk 827.87 mio sheet rights issue plan suppress their shares price to IDR4,600 this afternoon, corrects IDR25 price or equivalent to 0.54%.

Based on their prospectus published in newspaper today, the IDR1.9 trillion--3.6 trio rights issue plan indicated already formed its range price on the market related to non premium offered to capital market investors on the event.

Chandra Asri Petrochemical opens rights issue opportunity

BI / exchange

6/3/2011

Irvin Avriano A. & Yusuf Waluyo Jati

Bisnis Indonesia

Chandra Asri Petrochemical opens rights issue opportunity

JAKARTA: PT Chandra Asri Petrochemical Tbk, a company results of PT Tri Polyta Indonesia Tbk and PT Chandra Asri merger, intends to held a limited public offering with the right of preemptive (rights issue).

The corporate action potentially accelerate the medium term fund-raising process. Meanwhile, the medium-term funding needs of the company reached US$400 million.

Amstelco nonpreemptive price IDR10,000, confusing?

bursa

3/3/2011

Irvin Avriano A.

Amstelco nonpreemptive price IDR10,000, confusing?

JAKARTA: PT Amstelco Indonesia Tbk intends to held a nonpreemptive rights (non-HMETD) as much as 10% of their listed shares and with minimum price of IDR10,000 within a 12 months period.

The matter was announce by the company that used to be named PT Indocitra Finance Tbk in the Indonesia Stock Exchange (IDX/Bursa Efek Indonesia/BEI) information disclosure yesterday.

ABDA will raise IDR106.91 bio from rights issue

BI/bursa
1/3/2011
Irvin Avriano A.
Bisnis Indonesia

ABDA will raise IDR106.91 bio from rights issue

JAKARTA: PT Asuransi Bina Dana Artha Tbk tapped a rights issue price at IDR310 level that formed its fund will raised IDR106.91 billion.

The company will issue 344.89 million B series shares nominally IDR300. For each four shares holder have five rights that will issued by the listed insurance company, which shares coded ABDA.

Amstelco pocketed interest new standby buyers

BI/bursa

1/3/2011
Irvin Avriano A.
Bisnis Indonesia

Amstelco pocketed interest new standby buyers

JAKARTA: PT Amstelco Indonesia Tbk (previously PT Indocitra Finance Tbk) pocketed interest from several new potential future shareholder that intend to absorb new shares in their IDR5.1 trillion rights issue. Previously, the standby buyer only Amco Plc.

"We obtain several interesting institution, either from local or foreign investors," said Robert J.H. Bonnier to the press this beginning of the week.

BTPN 1:5 stock split approved

27/2/2011

Irvin Avriano A.

BTPN 1:5 stock split approved

JAKARTA: PT Bank Tabungan Pensiunan Nasional Tbk (BTPN) gets approval from its shareholders to split its stock nominal price with 1:5 ratio, or from IDR100 to IDR20.

"We hope the action can make our shares liquidity jacked up in the stock market, and its price reachable for retail investors," said Jerry Ng, BTPN President Director, in an information disclosure to Indonesia Stock Exchange (IDX/Bursa Efek Indonesia/BEI) last weekend.

Kertas Basuki Rachmat reduce rights issue to IDR596.85 bio

BI / exchange

18/11/2010

Irvin Avriano A.

Bisnis Indonesia

Kertas Basuki Rachmat reduce rights issue to IDR596.85 bio

JAKARTA: PT Kertas Basuki Rachmat Indonesia Tbk plans to reduce the value of its rights issue plan worth IDR604.29 billion to IDR596.85 bio.

In the company revised prospectus published today indicated the allocation of funds for working capital of the company fell from IDR9.41 bio, which was announced in the previous prospectus, to IDR1.97 bio.

The majority of funds from the issuance of the company new shares will still be used to pay off its debt to Quest Corporation amounting to IDR544.87 bio. The company also plans to use the rights issue funds to pay costs to restructure its debt to the Quest of IDR50 bio.

The company's old prospectus indicated the portion of the existing shareholders of the company could be diluted at a maximum of 75.61% if not execute its preemptive rights and warrants that will issued by the company.

However, in the revised of the new prospectus not show the potential reduction in ownership portion of the of investors after the rights issue executed.

The paper producer also has appointed PT Henan Putihrai as its standby buyer, which refers to the investors who managed under the securities company.

In that corporate action, the company issued a total of 5.98 bio C series new shares with a nominal value of IDR100 and IDR101 offering price per share. The value of new stock is as much as 75.61% of the total shares of the company.

The company also issued a total of 199.43 million IInd warrants. The warrants were valued at IDR20.94 bio with a nominal value of IDR100 and IDR105 offered value.